At the Heart of Cancer
SPECIAL
CLINICAL
SECTION:
CARDIOLOGY
MORE THAN 325,000 PEOPLE LIVING IN THE UNITED STATES HAVE SURVIVED CHILDHOOD
CANCER, BUT TREATMENTS CRITICAL TO ACHIEVING REMISSION PLACE THESE PATIENTS
INTO ANOTHER HIGH-RISK GROUP, WHERE LATENT EFFECTS CAN LEAD TO FATAL
OUTCOMES DECADES AFTER THEIR CANCER HAS BEEN DEFEATED.
By Michael Ferguson
T
HE FIRST GENERATIONS of childhood cancer patients who benefited
from significant treatment advances in recent decades are reaching
their 30s, but the threat of treatment-related cardiotoxicity is only
beginning to be fully realized. The American Heart Association
(AHA) has taken the first step to develop clinical guidelines that maintain
the current curative trajectory of childhood cancers and assuage the
possibility of cardiac disease later in life.
Steven E. Lipshultz, MD, FAHA,
George E. Batchelor Professor of
Pediatrics and Director of the
Batchelor Children's Research
Institute at the University
of Mia mi Miller School
1 4
|
Lower Hudson/Bronx MD NEWS ■ M D N E W S . CO M